GeoVax Labs (GOVX) Could Find a Support Soon, Here's Why You Should Buy the Stock NowZacks Investment Research • 06/12/26
GeoVax Labs, Inc. (GOVX) Discusses Building a Resilient Infectious Disease Preparedness Strategy Focused on Ebola, Marburg, Hantavirus, and Mpox TranscriptSeeking Alpha • 05/28/26
All You Need to Know About GeoVax Labs (GOVX) Rating Upgrade to BuyZacks Investment Research • 05/15/26
GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock?Zacks Investment Research • 08/20/25
GeoVax to Present at the Noble Capital Markets Twentieth Annual Emerging Growth Equity ConferenceGlobeNewsWire • 11/26/24
GeoVax Reports Third Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 11/12/24
GeoVax to Report Third Quarter 2024 Financial Results and Provide Corporate Update on November 12, 2024GlobeNewsWire • 11/05/24
GeoVax to Participate in the 3rd Annual ROTH Healthcare Opportunities ConferenceGlobeNewsWire • 10/02/24
GeoVax to Raise Approximately $5.0 Million of Gross Proceeds in Offering Priced At-the-MarketGlobeNewsWire • 08/29/24
GeoVax to Raise Approximately $8.5 Million of Gross Proceeds in Offering Priced Above-the-MarketGlobeNewsWire • 08/20/24
Presenting on the Emerging Growth Conference 74 Day 1 on August 21 Register NowGlobeNewsWire • 08/20/24